Artesunate Amivas Amivas Australia Pty Ltd
Product name
Artesunate Amivas
Sponsor
Accepted date
Aug-2024
Active ingredients
Artesunate
Proposed indication
Initial treatment of severe malaria in adults and children
Application type
A (new medicine)
Publication date
Aug-2024
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.
Priority review
Involves faster TGA evaluation of vital and life-saving medicines for which a complete data dossier is available.